Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$52.10 – $67.50
81% from low
Exchange
OTC Link
OS
NOVONESIS A S
No one on the platform currently holds NVZMF.
No tracked institution reports a position in NVZMF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-03-25 | $4.2500 | 2026-03-26 |
| 2025-08-22 | $2.2500 | 2025-08-27 |
| 2025-04-07 | $4.2000 | 2025-04-08 |
| 2024-08-30 | $2.0000 | 2024-09-03 |
| 2024-05-01 | $2.0000 | 2024-05-03 |
| 2023-10-11 | $4.2000 | 2023-10-19 |
| Execution date | Ratio |
|---|---|
| 2011-11-28 | 5-for-1 |
No one on the platform has traded NVZMF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $33.5B | +7.2% | $15.57 | $15.17–$16.16 | 4.2× | 4 |
| 2027 | $36.0B | +7.5% | $17.30 | $16.86–$17.95 | 3.7× | 4 |
| 2028 | $38.7B | +7.4% | $19.05 | $18.56–$19.77 | 3.4× | 5 |
| 2029 | $41.6B | +7.6% | $21.84 | $21.28–$22.66 | 3.0× | 4 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 2 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-05-05 | $0.81 | $0.64 | -21.4% |
| 2026-02-25 | $0.79 | $0.53 | -33.1% |
| 2025-11-06 | $0.64 | $0.48 | -24.8% |
| 2025-08-21 | $0.68 | $0.42 | -37.4% |
| 2025-05-08 | $0.43 | $0.06 | -86.2% |
| 2025-02-26 | $0.53 | $0.66 | +24.0% |
| 2024-11-07 | $0.57 | $0.40 | -30.0% |
| 2024-08-27 | $0.63 |
| $0.66 |
| +5.4% |
| $37.1B |
| — |
| APDAir Products and Chemicals, Inc. | $308.97 | +1.13% | $68.8B | — |
| AVOAAvoca LLC | $1200.00 | +0.00% | $10M | — |
Source: Financial Modeling Prep · peers by sector/industry